Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | BI 882370 |
| Trade Name | |
| Synonyms | XP-102|BI-882370|BI882370|XP 102|XP102 |
| Drug Descriptions |
BI 882370 is a Raf kinase inhibitor with potent activity against the inactive conformation of Braf and may result in tumor regression (PMID: 26916115). |
| DrugClasses | BRAF Inhibitor 26 RAF Inhibitor (Pan) 29 |
| CAS Registry Number | 1392429-79-6 |
| NCIT ID | C187123 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Afatinib + BI 882370 | Afatinib BI 882370 | 1 | 0 |
| BI 882370 | BI 882370 | 0 | 1 |
| BI 882370 + Cetuximab | BI 882370 Cetuximab | 1 | 0 |
| BI 882370 + Trametinib | BI 882370 Trametinib | 2 | 1 |